Business Context and Reporting Period
This Form 6-K filing by MDxHealth SA, a foreign private issuer, covers the month of August 2022. The report, dated August 19, 2022, serves to furnish a press release (Exhibit 99.1) issued by the Company on that date. The filing explicitly states that the information contained in the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural submission to attach a press release and does not contain a financial statement or quantitative performance data within the provided text.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. The content is limited to the administrative details of submitting the August 19, 2022, press release.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. While a press release is attached as Exhibit 99.1, the specific content of that release is not included in the provided text, preventing a summary of management's commentary or risk factors.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release dated August 19, 2022) for the specific material event or announcement triggering this filing.
- Verify the Company's status as a foreign private issuer filing under Form 20-F.
- Confirm that the press release information is not automatically incorporated by reference into other SEC filings.
- Check subsequent filings for any financial data or detailed commentary referenced in the August 19 press release.